October 24, 2009 |
A medication that is under review by the Food and Drug Administration for the treatment of type 2 diabetes may also promote weight loss, according to a study published online Thursday in the Lancet. The drug, liraglutide, was approved earlier this year in Europe for the treatment of diabetes. It is marketed under the brand name Victoza. Liraglutide is an injected drug that stimulates the release of insulin when glucose levels become too high. It also helps curb appetite. In the new study, researchers in Denmark assigned 564 obese people to one of four liraglutide doses, a placebo or the weight-loss drug orlistat.
October 15, 2012 |
Just a few nights of bad sleep is enough to throw the body's metabolism into disarray, according to a new study published Monday in the journal Annals of Internal Medicine. The study shows that getting four hours of sleep a night for four nights made healthy people's bodies resistant to insulin - a condition that is a common precursor of weight gain, diabetes and other serious health problems. In a healthy body, when you take in sugar, insulin is released from the pancreas and travels throughout the body, signaling to cells that they should absorb some of that new glucose.
August 9, 1992
As an Hispanic who has been recently diagnosed with diabetes mellitus, I read your article ("Minority Groups at Risk of Diabetes," July 21) with interest. I am currently enrolled in a research study at Harbor-UCLA Medical Center, Division of Endocrinology and Metabolism, that is investigating the effects of the drug glipizide on the blood-glucose levels in minorities. Through education received here, I have learned that with proper diet, medication, exercise, constant personal monitoring of my blood-sugar levels, and most of all, attitude adjustment, I will live a productive life.
August 12, 1993 |
Diabetics who have been barred from driving trucks or buses across state lines will be allowed to operate the vehicles if they meet stringent conditions, the federal government announced Wednesday. The Federal Highway Administration said insulin-using diabetics who qualify will be given waivers to drive the vehicles in interstate commerce for three years while the agency seeks to develop a permanent rule.
CALIFORNIA | LOCAL
July 1, 1998
UCLA was awarded a $3.5-million grant Tuesday to study how the brain responds to traumatic injury. The five-year grant from the National Institutes of Neurological Disorders and Stroke will fund a collaborative study by the Division of Neurosurgery and the Department of Molecular and Medical Pharmacology. "There is a traumatic brain injury occurring once every 10 seconds in the United States," said Donald Becker, chief of neurosurgery.
March 14, 2006 |
Abbott Laboratories said Monday that it had received approval from the Food and Drug Administration for a new blood glucose monitoring system -- an announcement that came as its stock rose to a six-month high. The go-ahead added to Abbott's momentum after the release of positive results from the first trial of its ZoMaxx device, a drug-coated stent intended to unclog arteries to the heart, Sunday at the American College of Cardiology's annual meeting in Atlanta.
September 22, 2011 |
Liposuction patients are usually after one thing: a better-looking body. But a new study suggests the cosmetic procedure that removes fat from well-padded areas of the body may also reduce harmful fat circulating in the blood. Research to be presented Sunday at the annual meeting of the American Society of Plastic Surgeons in Denver was aimed at measuring triglyceride levels in 229 people having liposuction. In people with normal triglyceride levels, cosmetic surgery made no difference.
June 27, 2013 |
Tucking into a breakfast of buttermilk pancakes and maple syrup, or a great bowl of white pasta for lunch, not only sends your blood sugar soaring--and then, suddenly, plummeting. Four hours after you've put down your fork, such a meal makes you hungrier than if you'd eaten one with more protein and fiber and fewer carbohydrates, a new study finds. The study also demonstrates that four hours later, the echo of that meal activates regions of the brain associated with craving and reward seeking more powerfully than does a meal with a lower "glycemic load.
November 15, 2004 |
All right, it's not the fountain of youth. But a study published in the Nov. 10 issue of the Journal of the American Medical Assn. has found that DHEA, a hormone widely marketed as a nutritional supplement, decreases belly fat and improves the body's use of insulin among the elderly when taken daily for six months. Earlier studies have shown that DHEA supplementation led to improved bone density and an enhanced sense of well-being. "We were surprised that there was such an effect," said Dr.
June 24, 2011 |
Weight-loss surgery can cure many obese people -- perhaps more than 60% of them -- of their diabetes, at least in the short term, suggests a new analysis of several studies. Though previous research had suggested that weight-loss surgery could reverse diabetes, researchers from the Netherlands have formalized the evidence a bit through a review of nine studies published in the June Archives of Surgery . Among the studies included in the analysis, 424 people with Type 2 diabetes underwent Roux-en-Y gastric bypass surgery, in which the surgeon creates a small pouch in the stomach that restricts food intake and bypasses part of the small intestines to cut down on absorption.